Real-time enrollment status for this heart failure with reduced ejection fraction clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 10:59 AM UTC
| NCT Number | NCT06831825 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure With Reduced Ejection Fraction |
| Phase | Clinical Trial |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | YAP Therapeutics, Inc. |
| Last Updated on CT.gov | April 27, 2025 (Apr 27, 2025) |
As of July 13, 2026: Clinical trial NCT06831825 is currently recruiting participants. This clinical trial study for heart failure with reduced ejection fraction is actively seeking new participants at 1 location across the United States. The study is sponsored by YAP Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06831825 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06831825 was last updated Apr 27, 2025 (April 27, 2025). HelloStudys verifies this status automatically.